References
- 1. Aoki H., Nosho K., Igarashi H., Ito M., Mitsuhashi K., Naito T., Yamamoto E., Tanuma T., Nomura M., Maguchi H, Shinohara T, Suzuki H., Yamamoto H., Shinomura Y. MicroRNA-31 expression in colorectal serrated pathway progression // World Journal of Gastroenterology, 2013; 20(34); 12346-1234910.3748/wjg.v20.i34.12346416182225232271
- 2. Chung S., Dwabe S., Elshimali Y., Sukhija H., Aroh C., Vadgama JV. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis- Antibody Array and Intracellular Signaling Array // PLoS ONE, 2015; 10(8): e0134948.doi:10.1371/ journal.pone.013494810.1371/journal.pone.0134948453095326258407
- 3. Coppede F., Lopomo A., Spisni R., Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer // World Journal of Gastroenterology, 2014; 20(4): 943-956
- 4. Edwards M.S., Chadda S. D., Zhao Z., Barber B. L. Sykes D. P. A systematic review of treatment guidelines for metastatic colorectal cancer // Color. Dis., 2012; 14: 31-47
- 5. Gonzalez-Pons M., Cruz-Correa M. Colorectal Cancer Biomarkers: Where Are We Now? // BioMed Research International, 2015: 1-1410.1155/2015/149014446172626106599
- 6. Greene F. L., Sobin L. H. The Staging of Cancer: A Retrospective and Prospective Appraisal // CA Cancer J Clin, 2008; DOI: 10.3322/CA.2008.000110.3322/CA.2008.000118460593
- 7. Kirstein M. M., Lange A., Prenzler A., Manns M. P., Kubicka S., Vogel A. Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data // The Oncologist, 2014; 19:1156-1168
- 8. Lei S.L., Zhao H., Yao H. L., Chen Y., Lei Z. D., Liu K. J., Yang Q. Regulatory roles of microRNA708 and microRNA31 in proliferation, apoptosis and invasion of colorectal cancer cells // Oncology Letters, 2014; 8: 1768-1774
- 9. Mazeh H., Mizrahi I., Ilyayev N., Halle D., Brücher LDM B., Bilchik A., Protic M., Daumer M., Stojadinovic A., Avital I., Nissan A. The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review // Journal of Cancer; 2013; 4(3): 281-295. doi: 10.7150/jca.583610.7150/jca.5836358484123459799
- 10. Peng Y., Zhai Z., Li Z., Wang L., Gu J. Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer // Int J Clin Exp Med, 2015; 8(1):982-990
- 11. Reimers M. S., Zeestraten E. C.M., Kuppen P. J.K., Liefers G. J., van de Velde C.J.H. Biomarkers in precision therapy in colorectal cancer // Gastroenterology Report 2013; 166-183, doi:10.1093/gastro/got02210.1093/gastro/got022393799724759962
- 12. Ross J. S., Torres-Mora J., Wagle N., Jennings T. A., Jones D. M. Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer // American Society for Clinical Pathology, 2010; 134:478-490
- 13. Schee K., Boye K., Weum Abrahamsen T., Fodstad O., Flatmark K. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer // 2012; Bio Med Central Cancer 12:50510.1186/1471-2407-12-505351962223121918
- 14. Sun D., Yu F., Ma Y., et al. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1) // Journal of Biological Chemistry. 2013; 288(13):9508-9518
- 15. Wang J., Huang S., Zhao M., Yang M., Zhong J., Gu Y., Peng H., Che Y., Huang C. Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection // PLOS ONE, 2014; 9(4) e87451: 1-910.1371/journal.pone.0087451397785424709885
- 16. Xu X. M., Qian J. C., Deng Z. L., Cai Z., Tang T., Wang P., Zhang K. H., Cai J.I.P. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer // Oncology Letters, 2012; 4: 339-345